Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001
Public ClinicalTrials.gov record NCT02336685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the efficacy, safety, and tolerability of fulranumab as adjunctive therapy compared with placebo in participants with chronic moderate to severe pain and functional impairment from knee or hip osteoarthritis that is not adequately controlled by current pain therapy.
Study identification
- NCT ID
- NCT02336685
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2015 (Actual)
- Primary completion
- Sep 16, 2016 (Actual)
- Completion
- Sep 16, 2016 (Actual)
- Last update posted
- Oct 2, 2017
2015 – 2016
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Cerritos | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Stamford | Connecticut | — | — |
| Not listed | Lewes | Delaware | — | — |
| Not listed | Newark | Delaware | — | — |
| Not listed | Crystal River | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Opa-locka | Florida | — | — |
| Not listed | Port Orange | Florida | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Woodstock | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Rockford | Illinois | — | — |
| Not listed | Prairie Village | Kansas | — | — |
| Not listed | Lake Charles | Louisiana | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Frederick | Maryland | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Lake Success | New York | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Downingtown | Pennsylvania | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Wyomissing | Pennsylvania | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02336685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02336685 live on ClinicalTrials.gov.